Absci

Yahoo Finance • 23 days ago

Absci Q4 2025 Earnings Preview

* Absci (ABSI [https://seekingalpha.com/symbol/ABSI]) is scheduled to announce Q4 earnings results on Tuesday, March 24th, after market close. * The consensus EPS Estimate is -$0.17 [https://seekingalpha.com/symbol/ABSI/earnings/estima... Full story

Yahoo Finance • last month

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Absci Corporation Former Vertex executive to spearhead the clinical development of Absci’s expanding AI-designed therapeutics pipeline Chief Innovation Officer Andreas Busch to retire March 31, 2026 and will continue to co-chair Absci’s... Full story

Yahoo Finance • last month

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood is having a rough year as the co-founder, CEO and investment manager of Ark Invest. Her largest exchange-traded fund is trading 15% lower this year, a rough contrast to a winning year for many growth investors. She's not giving... Full story

Yahoo Finance • 3 months ago

Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial

Absci Corporation (NASDAQ:ABSI) is among the 12 Best Genomics Stocks to Invest In.Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial Absci Corporation (NASDAQ:ABSI) announced on December 4, 2025, that... Full story

Yahoo Finance • 5 months ago

SA Quant ranks Goldman's small-cap stocks with largest short interest

[Multi screen fintech investing gold and silver trading on digital screen corporating with AI artificial intelligence financial business data on commodity investment] primeimages Goldman Sachs analysts last week identified 50 small-cap st... Full story

Yahoo Finance • 5 months ago

Absci outlines dual ABS-201 proof-of-concept readouts by 2027 while prioritizing endometriosis expansion

Earnings Call Insights: Absci Corporation (ABSI) Q3 2025 MANAGEMENT VIEW * Sean McClain, Founder, CEO, President & Director, announced "interim Phase I results for ABS-101, acceleration of ABS-201 development in androgenetic alopecia (... Full story

Yahoo Finance • 6 months ago

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash. and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will be participating... Full story

Yahoo Finance • 6 months ago

Absci spikes as J.P. Morgan starts at Buy ahead of key catalyst

[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images * Absci (NASDAQ:ABSI [https://seekingalpha.com/symbol/ABSI]) shares traded higher on Thursday after J.P. Morgan initiated its coverage on the AI-driven biotech with a... Full story

Yahoo Finance • 7 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Corporation; Oracle; AMD Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs AUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 (GLO... Full story

Yahoo Finance • 8 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

VANCOUVER, Wash. and NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced that world-renowned dermatologists Dr. Rodney... Full story

Yahoo Finance • 8 months ago

Absci Corp (NASDAQ:ABSI) Q2 2025 Earnings: Revenue Miss Sparks Market Selloff

ABSCI CORP (NASDAQ:ABSI) REPORTS Q2 2025 EARNINGS: REVENUE MISSES ESTIMATES, MARKET REACTS NEGATIVELY Absci Corp (NASDAQ:ABSI [https://www.chartmill.com/stock/quote/ABSI]) reported its second-quarter 2025 financial results, revealing a re... Full story

Yahoo Finance • 8 months ago

Absci GAAP EPS of -$0.24 misses by $0.03, revenue of $0.6M misses by $0.61M

* Absci press release [https://seekingalpha.com/pr/20198634-absci-reports-business-updates-and-second-quarter-2025-financial-and-operating-results] (NASDAQ:ABSI [https://seekingalpha.com/symbol/ABSI]): Q2 GAAP EPS of -$0.24 misses by $0.... Full story

Yahoo Finance • 8 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Strengthened balance sheet raising approximately $64 million in gross proceeds in July 2025; cash, cash equivalents, and short-term investments now sufficient to fund operations into the first half of 2028 Expanded ongoing collaboration w... Full story

Yahoo Finance • 8 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Almirall selects second target in AI Drug Creation collaborationExpanded collaboration builds on Absci’s successful de novo molecule design for difficult‑to‑drug targets in the first stage of the collaboration with Almirall BARCELONA, Spa... Full story

Yahoo Finance • 9 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

VANCOUVER, Wash. and NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative design, today announced the company will re... Full story

Yahoo Finance • 9 months ago

Cathie Wood's ARK ETF adjusts portfolio, buys ABSCI, sells CRISPR

In the latest trading session, Cathie Wood’s ARK ETFs made several significant transactions as part of their ongoing portfolio adjustments. On Friday, July 25th, 2025, the most substantial trade came from the purchase of 2,248,226 shares o... Full story

Yahoo Finance • 9 months ago

Absci Prices $50 Mln Public Offering To Advance AI-Driven Drug Programs

(RTTNews) - Absci Corporation (ABSI), a clinical-stage biopharma company leveraging generative AI for drug discovery, has priced an underwritten public offering of 16.67 million shares of its common stock at $3.00 per share. The offering... Full story

Yahoo Finance • 9 months ago

Absci announces proposed public offering of common stock

* Absci (NASDAQ:ABSI [https://seekingalpha.com/symbol/ABSI]) on Thursday said it has commenced an underwritten public offering of $50 million of shares of its common stock. * Absci also intends to grant the underwriters a 30-day option... Full story

Yahoo Finance • 9 months ago

Absci Announces Proposed Public Offering of Common Stock

VANCOUVER, Wash., July 24, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a clinical-stage biopharmaceutical company advancing potential breakthrough therapeutics designed with generative AI, announced today that it... Full story

Yahoo Finance • 9 months ago

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retire... Full story